- Your cart is empty
- Continue Shopping
HCQs 300
HCQs 300
Hydroxychloroquine
Price range: $20.00 through $50.00
Tablets
Choose an option
Add to cart
Buy Now
📋 Product Overview Table
| 🌟 Parameter | 🔍 Details |
|---|---|
| 🧬 Active Ingredient | Hydroxychloroquine Sulfate |
| 💊 Indication | Rheumatoid Arthritis, Lupus, Malaria Prophylaxis |
| 🇺🇸 US Brand Equivalent | Plaquenil |
| 🏭 Manufacturer | Ipca Laboratories Ltd |
| 📦 Packaging | 10 tablets per strip |
| 💪 Strength | 300 mg |
| 🚚 Delivery Time | 6–15 days (Ships to US, UK, Australia) |
🧬 What is HCQs 300 mg (Hydroxychloroquine Sulfate)?
HCQs 300 mg by Ipca Laboratories Ltd is a higher-strength generic version of Hydroxychloroquine Sulfate, widely used in the treatment of autoimmune disorders such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as malaria prophylaxis. This dosage offers flexibility for patients who require titrated therapy or adjustments from the standard 200 mg dose.
Ipca Laboratories is a globally recognized Indian pharmaceutical company, known for its dedication to quality and innovation in antimalarial and rheumatologic drugs. HCQs 300 mg provides a reliable alternative to branded Plaquenil, particularly for patients in need of tailored dosing regimens.
🎬 Educational Video Placeholder
🩺 Doctor’s Expert Commentary
Dr. Rajeev Nair, MD (Immunology):
“Higher-dosed formulations like HCQs 300 mg allow for better flexibility in adjusting treatment to patient needs while maintaining the therapeutic effects and safety expected from hydroxychloroquine.”
💉 Dosage & Administration
| 💡 Condition | 💊 Typical Dosage | ⏱️ Frequency | 📋 Notes |
|---|---|---|---|
| Rheumatoid Arthritis (RA) | 200–400 mg daily | Once or divided dose | Adjusted based on clinical response |
| Systemic Lupus Erythematosus | 200–400 mg daily | Once daily | Higher dose in flare-up phase |
| Malaria Prophylaxis | 400 mg once weekly | Weekly | Begin 2 weeks before exposure |
⚠️ Side Effects, Warnings & Storage
- Common Effects: Nausea, stomach upset, visual disturbances
- Serious Risks: Retinopathy (especially at high doses), QT prolongation, cardiotoxicity
- Warnings: Regular eye exams advised; not recommended in patients with existing retinal disease
- Storage: Store below 25°C, protect from moisture and light
🌍 Global Availability
| 🌐 Country | 🚚 Shipping Available | 💵 Price (per strip) | 📜 Prescription Required |
|---|---|---|---|
| 🇺🇸 USA | ✅ Yes | $7–$13 | Yes |
| 🇬🇧 UK | ✅ Yes | £6–£11 | Yes |
| 🇦🇺 Australia | ✅ Yes | AUD 12–16 | Yes |
🔗 Related Indian Alternatives (Same Therapeutic Class)
| 💊 Product Name | 🏭 Manufacturer | 🔗 Link |
|---|---|---|
| HCQ 300 Tablet | Torrent Pharmaceuticals | HCQ 300 Tablet |
| Malirid DS | Ipca Laboratories | Malirid DS |
| Zydus Lefno 10 | Zydus Cadila | Lefno 10 |
| Folitrax 7.5 | Ipca Laboratories | Folitrax 7.5 |
| Saaz 500 | Wallace Pharma | Saaz 500 |
📚 Trusted Medical References
⚠️ Medical Disclaimer
This content is intended for informational purposes only and should not replace professional medical consultation. Always seek advice from a certified healthcare provider
Additional Information
| Active | Hydroxychloroquine |
|---|---|
| Tablets | 30, 60, 90 |
Related products
